Barclays Boosts UnitedHealth Group (NYSE:UNH) Price Target to $386.00

UnitedHealth Group (NYSE:UNH) had its target price boosted by research analysts at Barclays from $352.00 to $386.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s target price indicates a potential upside of 8.95% from the company’s previous close.

Other equities research analysts have also issued research reports about the stock. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Morgan Stanley increased their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Sanford C. Bernstein increased their price target on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a report on Wednesday. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Price Performance

NYSE:UNH opened at $354.30 on Thursday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50 day moving average price of $318.21 and a 200 day moving average price of $350.41. The stock has a market cap of $320.88 billion, a PE ratio of 15.35, a P/E/G ratio of 2.38 and a beta of 0.47. UnitedHealth Group has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 EPS. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its holdings in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC boosted its holdings in UnitedHealth Group by 3.3% in the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock valued at $6,624,411,000 after purchasing an additional 675,075 shares during the period. Norges Bank acquired a new stake in UnitedHealth Group in the second quarter valued at $3,837,207,000. Finally, Dodge & Cox raised its stake in UnitedHealth Group by 117.7% in the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock valued at $2,729,912,000 after buying an additional 4,730,192 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.